These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of FR167653 on pulmonary ischemia-reperfusion injury in dogs. Kamoshita N; Takeyoshi I; Ohwada S; Iino Y; Morishita Y J Heart Lung Transplant; 1997 Oct; 16(10):1062-72. PubMed ID: 9361249 [TBL] [Abstract][Full Text] [Related]
3. [Effect of FR167653 on pulmonary ischemic reperfusion injury in rats]. Otani Y; Takeyoshi I; Iino Y; Yokoe T; Matsumoto K; Sato S; Muramoto M; Morishita Y Nihon Geka Gakkai Zasshi; 1997 Oct; 98(10):893. PubMed ID: 9490379 [No Abstract] [Full Text] [Related]
4. The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. Otani Y; Takeyoshi I; Koibuchi Y; Matsumoto K; Muramoto M; Morishita Y J Heart Lung Transplant; 2000 Apr; 19(4):377-83. PubMed ID: 10775819 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. Yamada T; Murase N; Maeda T; Ye Q; Sakamoto T; Terakura M; Starzl TE; Todo S Transplant Proc; 1998 Sep; 30(6):2638. PubMed ID: 9745524 [No Abstract] [Full Text] [Related]
6. Attenuation of microcirculatory disturbance after liver ischemia by newly synthesized inflammatory cytokine suppressor, FR167653. Takiguchi M; Totsuka E; Umehara M; Ono H; Nara M; Nozaki T; Wajima N; Takahashi K; Narumi S; Hakamada K; Sugai M; Sasaki M Hepatogastroenterology; 2003; 50(51):789-93. PubMed ID: 12828086 [TBL] [Abstract][Full Text] [Related]
8. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Yoshinari D; Takeyoshi I; Koibuchi Y; Matsumoto K; Kawashima Y; Koyama T; Ohwada S; Morishita Y Crit Care Med; 2001 Mar; 29(3):628-34. PubMed ID: 11373433 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of liver and lung injury after hepatic ischemia and reperfusion by a cytokine-suppressive agent, FR167653. Hato S; Urakami A; Yamano T; Uemura T; Ota T; Hirai R; Shimizu N Eur Surg Res; 2001; 33(3):202-9. PubMed ID: 11490123 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs. Kitada H; Sugitani A; Yamamoto H; Otomo N; Okabe Y; Inoue S; Nishiyama K; Morisaki T; Tanaka M Surgery; 2002 Jun; 131(6):654-62. PubMed ID: 12075178 [TBL] [Abstract][Full Text] [Related]
11. The effective dose of FR167653 in pulmonary ischemia-reperfusion injury. Ishikawa H; Takeyoshi I; Aiba M; Kamoshita N; Ohwada S; Matsumoto K; Morishita Y Int J Surg Investig; 2000; 2(3):243-52. PubMed ID: 12678525 [TBL] [Abstract][Full Text] [Related]
12. FR167653, a cytokine-suppressive agent, reduces myocardial ischemia-reperfusion injury in rats. Hoshida S; Yamashita N; Otsu K; Hori M Cytokines Cell Mol Ther; 2000 Dec; 6(4):165-70. PubMed ID: 11565954 [TBL] [Abstract][Full Text] [Related]
13. Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats. Wei YH; Li Y; Qiang CJ Int Immunopharmacol; 2004 Dec; 4(13):1625-32. PubMed ID: 15454115 [TBL] [Abstract][Full Text] [Related]
14. FR167653 improves survival and pulmonary injury after partial hepatectomy under ischemia/reperfusion in rats. Watanabe M; Yamaguchi K; Chijiiwa K; Tanaka M J Surg Res; 2001 Dec; 101(2):146-51. PubMed ID: 11735269 [TBL] [Abstract][Full Text] [Related]
15. Effect of FR167653 on small bowel ischemia-reperfusion injury in dogs. Takeyoshi I; Iwanami K; Ohwada S; Kawashima Y; Kawata K; Aiba M; Kobayashi J; Koyama T; Matsumoto K; Satoh S; Morishita Y Dig Dis Sci; 1999 Nov; 44(11):2334-43. PubMed ID: 10573384 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of FR167653 on cold ischemia/reperfusion injury in rat liver transplantation. Hashimoto K; Nishizaki T; Yoshizumi T; Uchiyama H; Okano S; Ikegami T; Yanaga K; Sugimachi K Transplantation; 2000 Nov; 70(9):1318-22. PubMed ID: 11087146 [TBL] [Abstract][Full Text] [Related]
17. FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury. Cau J; Favreau F; Zhang K; Febrer G; de la Motte GR; Ricco JB; Goujon JM; Hauet T J Vasc Surg; 2009 Mar; 49(3):728-40. PubMed ID: 19268775 [TBL] [Abstract][Full Text] [Related]
18. Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury. Yao HW; Yue L Inflamm Res; 2005 Nov; 54(11):471-7. PubMed ID: 16307221 [TBL] [Abstract][Full Text] [Related]
19. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to university of wisconsin solution on reperfusion injury in liver transplantation. Yoshinari D; Takeyoshi I; Kobayashi M; Koyama T; Iijima K; Ohwada S; Matsumoto K; Morishita Y Transplantation; 2001 Jul; 72(1):22-7. PubMed ID: 11468529 [TBL] [Abstract][Full Text] [Related]
20. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Furuichi K; Wada T; Iwata Y; Sakai N; Yoshimoto K; Kobayashi Ki K; Mukaida N; Matsushima K; Yokoyama H Nephrol Dial Transplant; 2002 Mar; 17(3):399-407. PubMed ID: 11865084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]